Acetaminophen and the developing lung: could there be lifelong consequences?

The use of acetaminophen (paracetamol, APAP) in the neonatal intensive care unit (NICU) has become ubiquitous. Between 2005-2010, APAP was the 15th most common pharmacologic exposure among infants admitted to the Pediatrix-affiliated NICUs in the United States.1 Over nearly the same period of time, a significant increase in the use of APAP was reported in German NICUs, occurring in 8.1% of all infants with very low birth weights by 2010.2 Since 2010, multiple reports indicate increasing APAP use in NICUs around the world.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Commentary Source Type: research